When There's No Time for HAART to Start ...

Chicago - In the early days before protease inhibitors, Kaposi's sarcoma was considered a severe and dangerous ancillary condition that often was fatal to patients.

Related Videos
Related Content

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Indoor Tanning and Melanoma

March 21st 2023

Skin Barrier 101: Keep Up with What Your Patients Are Reading

March 21st 2023

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Indoor Tanning and Melanoma

March 21st 2023

Skin Barrier 101: Keep Up with What Your Patients Are Reading

March 21st 2023

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Indoor Tanning and Melanoma

March 21st 2023

Skin Barrier 101: Keep Up with What Your Patients Are Reading

March 21st 2023
© 2023 MJH Life Sciences

All rights reserved.